Peptide Segment Covered In Repor t: Cyclic-Peptide, Polypeptide, Glycopeptide, Glycopeptide, Oligopeptide, Depsipeptide, Neuropeptide, Dipeptides, Natriuretic Peptide, Lipopeptide
, Opioid Peptide, Peptide Vaccine, Antimicrobial Cationic Peptide & Insulin Global Peptide Therapeutics Pipeline Insight 2015 Report Highlights: - Global Peptide Therapeutics Market Overview - Global Peptide Therapeutics Pipeline By Peptide Type - Global Peptide Therapeutics Pipeline By Company, Indication & Phase - Peptide Therapeutics Clinical Pipeline: 743 Peptides - Majority Peptide Therapeutics in Preclinical Phase: 293 Peptides - Commercially available Peptides: 126 Peptides Key Topics Covered: 1.
Matrixyl Synthe 6 is a dioxgenated lipopeptide
naturally found in collagen VI and laminins.
The above results revealed that the isolated biosurfactant of PDKT-1, PDKT-5 and PDKT-2 belong to lipopeptide
and rhamnolipid type respectively.
A cyclic lipopeptide
antibiotic--a new antibiotic class--approved for treating patients with Staphylococcus aureus bacteremia, including those with right-sided infective endocarditis caused by methicillin-susceptible and methicillin-resistant isolates.
University of Utah (Salt Lake City, UT) has patented amphiphilic lipopeptide
compositions for gene delivery are disclosed.
This meeting report summarizes the symposium proceedings that focused on increasing knowledge of the structure and function of this ubiquitous superfamily of membrane receptors and their potential modulation for disease treatment, and how GPCR mechanisms might be exploited to treat diseases with pepducins, novel synthetic lipopeptide
pharmacophores that modulate heptahelical GPCR activity from inside the cell membrane.
subtilis for different commercial purposes; enzyme production, synthesis of lipopeptide
(antibiotics) or as probiotics additive.
Colistin, also known as polymyxin E, is a cationic lipopeptide
antibiotic isolated from Bacillus polymyxa subsp.
Cubist developed and commercialized CUBICIN (daptomycin for injection), a Gram-positive first-in-class lipopeptide
The new anti-aging, in vivo study was performed on 20 volunteers to evaluate the efficacy of the product versus a well-known benchmark lipopeptide
TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious and degenerative diseases will have five posters related to the company's lipopeptide
compound, MX-2401 presented at the American Society for Microbiology's 46th Annual International Conference on Antimicrobial Agents and Chemotherapy (ICAAC) being held in San Francisco September 27th-30th, 2006.
TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious and degenerative diseases, has obtained positive results on the effectiveness of its lipopeptide
anti-bacterial product candidate, MX-2401, in accepted experimental models of pneumonia and soft tissue infections.